Description of the outcome according to prognostic indexes
| . | No. risk factors . | Training series . | Lille test series . | LPRR test series . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patients (%) . | Survival rate (%) . | Patients (%) . | Survival rate (%) . | % of patients . | Survival rate (%) . | |||||
| 2 y . | 5 y . | 2 y . | 5 y . | 2 y . | 5 y . | |||||
| Prognostic index, all patients5-150 | ||||||||||
| Low | 0 to 1 | 27 | 97 | 87 | 42 | 93 | 83 | 28 | 96 | 90 |
| Intermediate | 2 | 27 | 88 | 62 | 38 | 85 | 59 | 34 | 96 | 67 |
| High | 3 or 4 | 46 | 64 | 25 | 20 | 57 | 35 | 38 | 74 | 37 |
| Age-adjusted index, patients younger than 655-151 | ||||||||||
| Low | 0 | 86 | 94 | 75 | 80 | 91 | 74 | — | — | — |
| High | 1 | 14 | 53 | 13 | 20 | 50 | 33 | — | — | — |
| Age-adjusted index, patients 65 or older5-152 | ||||||||||
| Low | 0 | 12 | 100 | 92 | 5 | 100 | 80 | — | — | — |
| Intermediate | 1 | 23 | 78 | 63 | 38 | 81 | 52 | — | — | — |
| High | 2 | 65 | 64 | 27 | 56 | 59 | 35 | — | — | — |
| . | No. risk factors . | Training series . | Lille test series . | LPRR test series . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patients (%) . | Survival rate (%) . | Patients (%) . | Survival rate (%) . | % of patients . | Survival rate (%) . | |||||
| 2 y . | 5 y . | 2 y . | 5 y . | 2 y . | 5 y . | |||||
| Prognostic index, all patients5-150 | ||||||||||
| Low | 0 to 1 | 27 | 97 | 87 | 42 | 93 | 83 | 28 | 96 | 90 |
| Intermediate | 2 | 27 | 88 | 62 | 38 | 85 | 59 | 34 | 96 | 67 |
| High | 3 or 4 | 46 | 64 | 25 | 20 | 57 | 35 | 38 | 74 | 37 |
| Age-adjusted index, patients younger than 655-151 | ||||||||||
| Low | 0 | 86 | 94 | 75 | 80 | 91 | 74 | — | — | — |
| High | 1 | 14 | 53 | 13 | 20 | 50 | 33 | — | — | — |
| Age-adjusted index, patients 65 or older5-152 | ||||||||||
| Low | 0 | 12 | 100 | 92 | 5 | 100 | 80 | — | — | — |
| Intermediate | 1 | 23 | 78 | 63 | 38 | 81 | 52 | — | — | — |
| High | 2 | 65 | 64 | 27 | 56 | 59 | 35 | — | — | — |
LPRR, Lens, Paris, Rennes, and Rouen.
Adverse prognostic factors: age 65 or older, at least 1 cytopenia, at least 2 cytopenias, and albumin level less than 40 g/L.
Adverse prognostic factor: at least 2 cytopenias.
Adverse prognostic factors: at least 1 cytopenia and albumin level less than 40 g/L.